Physician profile
Jun Song
NPI 1871025676
$19,937.17
in general payments reported to CMS, 2019-2025
10 companies · $2,745 in 2025
The $2,745 reported for 2025 was more than what 87% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $10K · 2022: $264 · 2023: $3,880 · 2024: $2,795 · 2025: $2,745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,804 · Travel and Lodging: $4,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,804.47 |
| Travel and Lodging | $4,615.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,260.02 | 2021-2025 | Interstim, Nuro |
| Coloplast Corp | $3,971.63 | 2023-2025 | Altis, Supris |
| Boston Scientific Corporation | $2,866.41 | 2021-2025 | General - Therapies, Solyx Sis System, Upsylon |
| Axonics, INC. | $260.33 | 2023-2024 | Axonics, Bulkamid |
| Abbvie INC. | $184.69 | 2023-2024 | Botox |
| Davol INC. | $147.37 | 2024 | Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals LP | $117.41 | 2023 | Andexxa |
| Ambu INC. | $69.56 | 2025 | |
| Intuitive Surgical, INC. | $34.75 | 2025 | |
| Femselect INC. | $25.00 | 2024 | Enplace |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jun Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.